COVID-19: Federal & Non-Federal Funding Opportunities
To facilitate COVID-19 research projects, the OVPR has formed a team to identify funding opportunities and other programs to support this work. These opportunities will be shared with the research community on an ongoing basis.
Last updated on August 20, 2021
Jump to:
Federal
Non-Federal
|
SPONSOR |
PROGRAM |
FUNDING |
DEADLINE |
Notes |
|
Russell Sage Foundation |
$30K - $50K |
Fall of 2021, exact date TBD |
Research to improve understanding of the severe consequences of the COVID-19 pandemic, including its economic disruptions, and the mass protests to combat systemic racism and racial inequality in policing and other institutions. |
|
| Russell Sage Foundation | Social, Political, Economic, and Psychological Consequences of the COVID-19 Pandemic | November 10, 2021 | ||
|
COVID-19 HPC Consortium |
The COVID-19 High Performance Computing (HPC) Consortium |
Not specified |
None specified |
Applications for computational resources on supercomputers around the world, software, services, and technical expertise to help COVID-19 researchers. |
|
Robert Wood Johnson Foundation |
Pioneering Ideas: Exploring the Future to Build a Culture of Health |
The average Pioneer grant in 2019 was $315,031. However, there is not an explicit range for budget requests. Grant periods are flexible, though generally range from 1 to 3 years. |
Open |
Proposals that address any of these four areas of focus: Future of Evidence; Future of Social Interaction; Future of Food; Future of Work. |
|
March of Dimes Foundation |
$200K to $300K |
9/10/2021 |
Pregnancy-related disorders and developmental origins of infant health and maternal morbidity and mortality. May include continued investigations into the effects of COVID-19 infections on maternal and infant health. |
|
|
Comcast Innovation Fund |
|
Up to $150K |
Ongoing |
COVID-19 effects on the Internet. Research grants and Open Source Development grants. |
|
Pfizer |
COVID Vaccine Research: https://www.pfizer.com/purpose/independent-grants/covid-19-vaccine https://www.pfizer.com/purpose/independent-grants
|
Undetermined |
Ongoing |
Studies evaluating COVID burden of disease and sero-epidemiological surveys among specific populations; Epidemiology studies evaluating direct & indirect impact, including modeling approaches, of Pfizer’s vaccine particularly in specific patient populations; Studies measuring the impact of efforts to overcome vaccine hesitancy and enhance vaccine uptake. |
|
Coalition for Epidemic Preparedness Innovations (CEPI) |
Global partnership founded in Davos by the governments of Norway and India, the Bill & Melinda Gates Foundation, Wellcome, and the World Economic Forum https://cepi.net/get_involved/cfps
|
Undetermined |
Ongoing |
Vaccine Drug Products in alternative primary packaging and delivery devices; Sourcing serum or plasma from individuals recovered from infection with SARS-CoV-2 variants for the development of antibody working standards and reference panels; Broadening protection against SARS-COV-2 and new broadly protective Betacoronavirus candidate vaccines; Wellcome Leap Program “R3: RNA Readiness and Response,” jointly funded with CEPI. |
|
Wellcome, the Bill & Melinda Gates Foundation and Mastercard |
COVID-19 Therapeutics Accelerator |
Undetermined |
Currently paused, will resume |
High risk pre-exposure prophylaxis (e.g. health workers); High risk post-exposure prophylaxis (e.g. close contacts); Mild disease treatment (outpatient); Moderate disease treatment (early hospitalization) |
|
Allen Institute for AI |
COVID-19 Open Research Dataset Challenge (CORD-19) |
$1,000 per task award. More details on prizes and timeline can be found on the discussion post. |
Ongoing |
Call to artificial intelligence experts to develop text and data mining tools that can help the medical community develop answers to high priority scientific questions. The CORD-19 dataset represents the most extensive machine-readable coronavirus literature collection available for data mining to date. |
|
Led by the University of North Carolina at Chapel Hill |
Rapidly Emerging Antiviral Drug Development Initiative (READDI). |
Undetermined |
Ongoing |
Research projects including virologists, medicinal chemists, and drug development experts from academia and industry, with specific expertise in developing antiviral drugs. |
|
Fast – Grants |
|
$10K to $500K |
Currently paused |
Scientists at academic institutions currently working on a COVID-19 related project are invited to apply for a Fast Grant; decisions made in under 14 days. |
|
Amazon Web Services (AWS) |
Amazon Web Services (AWS) Diagnostic Development Initiative (DDI) |
Undetermined |
Applications through December 31, 2021, with priority consideration given to applications received before July 31, 2021 |
$20M commitment to accelerate research in the detection of COVID-19 and other infectious diseases. Funding for early disease detection, diagnostics, prognosis, and public health genomics. |
|
The Mind & Life Institute |
Applicants are required to have attended the Mind & Life Summer Research Institute |
$20K |
August 18 to September 15, 2021 |
Contemplative science proposals that demonstrate relevance to the current COVID-19 pandemic. For instance, a proposed study may focus on a specific population and how it is being affected by COVID-19. |
Contact your Corporate and Foundation Relations representative if you would like to apply/are considering applying for these non-federal funding opportunities.